Literature DB >> 8674904

Diabetes and brain ischemia.

L R Caplan1.   

Abstract

Diabetes influences brain ischemia in a number of different ways. Diabetes causes and exacerbates macroangiopathies, increases the severity of ischemia, and increases stroke mortality. Unfortunately, few studies have examined in sufficient depth the influence of diabetes on the various vascular lesions that cause brain ischemia. These can be divided into: 1) cardiac-origin brain embolism; 2) atherosclerosis of the aorta and the large extracranial arteries--the internal carotid arteries (ICAs) and the vertebral arteries (VAs); 3) atherosclerosis of the large intracranial arteries--ICAs, anterior, middle, and posterior cerebral arteries, the VAs, and the basilar artery; 4) intracranial atheromatous branch disease of macroscopically visible branches of the intracranial arteries enumerated in 3; and 5) degenerative abnormalities such as lipohyalinosis and fibrinoid changes within penetrating artery branches visible only microscopically. The last three types of disorders all can cause deep subcortical brain infarcts, the predominant type of brain infarction found in Japan.

Entities:  

Mesh:

Year:  1996        PMID: 8674904     DOI: 10.2337/diab.45.3.s95

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Different risk factor profiles between subtypes of ischemic stroke. A case-control study in Korean men.

Authors:  Yun-Mi Song; Sun Uck Kwon; Joohon Sung; Shah Ebrahim; George Davey Smith; Sung Sunwoo; Yeong Sook Yun
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers.

Authors:  Joseph Levy; Zhengxian Zhu; Joseph C Dunbar
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

3.  Cerebral amyloid angiopathy presenting as nonhemorrhagic diffuse encephalopathy: neuropathologic and neuroradiologic manifestations in one case.

Authors:  M Caulo; D Tampieri; R Brassard; M Christine Guiot; D Melanson
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

4.  Acute hypertensive encephalopathy with widespread small-vessel disease at MRI in a diabetic patient: pathogenetic hypotheses.

Authors:  F Cotton; S Kamoun; F Rety-Jacob; V A Tran-Minh; N Nighoghossian; M Hermier
Journal:  Neuroradiology       Date:  2005-07-19       Impact factor: 2.804

5.  Significant association of metabolic syndrome with silent brain infarction in elderly people.

Authors:  Hyung-Min Kwon; Beom Joon Kim; Jin-Ho Park; Wi-Sun Ryu; Chi-Kyung Kim; Su-Ho Lee; Sang-Bae Ko; Hyunwoo Nam; Seung-Hoon Lee; Yong-Seok Lee; Byung-Woo Yoon
Journal:  J Neurol       Date:  2009-06-16       Impact factor: 4.849

6.  Isorhamnetin Alleviates High Glucose-Aggravated Inflammatory Response and Apoptosis in Oxygen-Glucose Deprivation and Reoxygenation-Induced HT22 Hippocampal Neurons Through Akt/SIRT1/Nrf2/HO-1 Signaling Pathway.

Authors:  Yuqin Wu; Lin Fan; Yun Wang; Jing Ding; Rongfu Wang
Journal:  Inflammation       Date:  2021-05-17       Impact factor: 4.092

7.  The Prediction of Clinical Outcome Using HbA1c in Acute Ischemic Stroke of the Deep Branch of Middle Cerebral Artery.

Authors:  Sung Bong Shin; Tae Uk Kim; Jung Keun Hyun; Jung Yoon Kim
Journal:  Ann Rehabil Med       Date:  2015-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.